Anti-Oxidative Therapy in Islet Cell Transplantation

Antioxidants (Basel). 2022 May 24;11(6):1038. doi: 10.3390/antiox11061038.

Abstract

Islet cell transplantation has become a favorable therapeutic approach in the treatment of Type 1 Diabetes due to the lower surgical risks and potential complications compared to conventional pancreas transplantation. Despite significant improvements in islet cell transplantation outcomes, several limitations hamper long-term graft survival due to tremendous damage and loss of islet cells during the islet cell transplantation process. Oxidative stress has been identified as an omnipresent stressor that negatively affects both the viability and function of isolated islets. Furthermore, it has been established that at baseline, pancreatic β cells exhibit reduced antioxidative capacity, rendering them even more susceptible to oxidative stress during metabolic stress. Thus, identifying antioxidants capable of conferring protection against oxidative stressors present throughout the islet transplantation process is a valuable approach to improving the overall outcomes of islet cell transplantation. In this review we discuss the potential application of antioxidative therapy during each step of islet cell transplantation.

Keywords: antioxidants; diabetes; islet cell transplantation; oxidative stress; pancreatic β cell replacement therapy.

Publication types

  • Review

Grants and funding

This research received no external funding.